-
Trial characteristics: <i>A</i>. <i>Paniculata</i> versus Placebo (n = 4).
Trial characteristics: A. Paniculata versus Placebo (n = 4). -
Trial characteristics: <i>A</i>. <i>Paniculata</i> (pillule) versus <i>A</i>....
Trial characteristics: A. Paniculata (pillule) versus A. Paniculata (tablet) (n = 3). -
Antibiotic cost reductions associated with CDS interventions.
Antibiotic cost reductions associated with CDS interventions. -
Length of stay associated with CDS implementation.
Length of stay associated with CDS implementation. -
Trial characteristics: <i>A</i>. <i>Paniculata</i> plus usual care versus Usu...
Trial characteristics: A. Paniculata plus usual care versus Usual care (n = 9). -
Reduction in overall antibiotic usage with CDS interventions in secondary care.
Reduction in overall antibiotic usage with CDS interventions in secondary care. -
Detail of the 10-point Quality Assessment Scale used in the present study.
Detail of the 10-point Quality Assessment Scale used in the present study. -
<i>Andrographis paniculata</i> (Chuān Xīn Lián) for symptomatic relief of acu...
IntroductionAntimicrobial resistance (AMR) is a substantial threat to public health. Safe and effective alternatives are required to reduce unnecessary antibiotic prescribing.... -
r37980778c78--f0b7914490d7485b76e02541eee4e20a
Trial characteristics: A. Paniculata versus Herbal active intervention (n = 5). -
Trial characteristics: <i>A</i>. <i>Paniculata</i> versus Usual care (n = 12).
Trial characteristics: A. Paniculata versus Usual care (n = 12). -
Demographic and clinical data.
Note. All figures are group means, with standard deviations in parentheses, unless otherwise stated. BDD = body dysmorphic disorder group; SZ = schizophrenia/schizoaffective... -
Characteristics of <i>A</i>. <i>Paniculata</i> used in the included trials.
Characteristics of A. Paniculata used in the included trials.
